Real-world safety and effectiveness of nivolumab in Japanese patients with unresectable advanced or recurrent gastric/gastroesophageal junction cancer that has progressed after chemotherapy: a postmarketing surveillance study.

Kensei YamaguchiNarikazu BokuKei MuroKazuhiro YoshidaHideo BabaShinji TanakaAyumi AkamatsuTakeshi Sano

Published in: Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association (2021)

The real-world safety and effectiveness of nivolumab as salvage (after ≥ 2 lines) therapy in Japanese patients with unresectable advanced or recurrent G/GEJ cancer were consistent with those observed in the phase 3 ATTRACTION-2 study.

Keyphrases

randomized controlled trial
papillary thyroid
locally advanced
systematic review
public health
squamous cell
squamous cell carcinoma
mesenchymal stem cells